Pinnacle Transplant Technologies is a tissue processor and contract manufacturing organization committed to honoring the gift of donation and improving patients' quality of life through the processing and distribution of high-quality allograft implants. We offer a comprehensive allograft portfolio, and private-label and custom allografts across multiple market segments, including Spine, Wound Care, Orthopedics, Sports Medicine, Trauma, and Dental. For over a decade, Pinnacle has helped surgeons improve the lives of thousands of patients. Pinnacle is registered with the U.S. Food and Drug Administration (FDA), accredited by the Association for Advancing Tissue and Biologics (AATB), and maintains all applicable state licenses. Safety and quality are our priority. We partner with tissue recovery organizations across the U.S. to acquire donated tissue and are committed to delivering quality customer service and solutions to our partners, customers, and healthcare professionals.
Looking for a particular Pinnacle Transplant Technologies employee's phone or email?
The Pinnacle Transplant Technologies annual revenue was $15.6 million in 2026.
Roger Rose is the President and Chief Executive Officer of Pinnacle Transplant Technologies.
67 people are employed at Pinnacle Transplant Technologies.
Pinnacle Transplant Technologies is based in Phoenix, Arizona.
The NAICS codes for Pinnacle Transplant Technologies are [621, 62199, 62, 6219, 621991].
The SIC codes for Pinnacle Transplant Technologies are [80, 809].